Q98428550

Summary

Q98428550 is an interpellation^[1].

Key Facts

• Q98428550 authored Penilla Gunther^[2].
• Q98428550's instance of is recorded as interpellation^[3].
• Q98428550's part of the series is recorded as interpellations of the 2017/18 legislative session of the Riksdag^[4].
• Q98428550's language of work or name is recorded as Swedish^[5].
• Q98428550 was published on +2018-06-01T00:00:00Z^[6].
• Q98428550's significant event is recorded as debate^[7].
• Q98428550's main subject is medication^[8].
• Q98428550's work available at URL is recorded as http://data.riksdagen.se/dokument/H510575^[9].
• Q98428550's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H510575^[10].
• Q98428550's work available at URL is recorded as http://data.riksdagen.se/fil/568D29B5-7D68-4A7B-9D4E-E7CBE5214F0E^[11].
• Q98428550's applies to jurisdiction is recorded as Sweden^[12].
• Q98428550's legal citation of this text is recorded as ip. 2017/18:575^[13].
• Q98428550's title is recorded as Studier på nya läkemedel^[14].
• Q98428550's addressee is recorded as Annika Strandhäll^[15].
• Q98428550's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q98428550's copyright status is recorded as public domain^[17].

Body

Definition and Type

Q98428550's instance of is recorded as interpellation^[3].